Mast cell, a new player in type 2 diabetes | ||||
| Kasr Al Ainy Medical Journal | ||||
| Volume 24, Issue 2, May 2018 PDF (279.85 K) | ||||
| DOI: 10.4103/kamj.kamj_18_18 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Nehal Hamdy; Randa F. Salam; Nagwa Abd EL-Ghaffar Mohamed | ||||
| Abstract | ||||
| Background Mast cells plays critical role in inflammatory diseases, including cardiovascular and metabolic diseases and their associated complications. These cells exert their physiological and pathological activities by releasing granules containing histamine, cytokines, chemokines, and proteases, including mast cell-specific chymases and tryptases Method 70 Type 2 diabetic obese patients attending the Diabetes and Endocrinology clinic in Kasr El Ani hospital compared to 15 healthy controls Results Statistical significant difference between patients and control regarding BMI, glucose,cholesterol, HDL, LDL,tryptase (p<0.001) ,triglycerides(p=0.001) Tryptase statistically correlated with BMI,fastingglucose,A1C,triglycerides(p=0.014,r=0.031)/(p=0.012,r=0.297)/(p<0.001,r=0.862),(p=0.039,r=0.247) Higher mean level of tryptase in patients with diabetic complications mainly in retinopathy (32.32 ng/ml) Conclusion Tryptase participate in the pathogenesis of diabetes mellitus and its complication targeting mast cells as novel therapy for diabetes requires further investigations | ||||
| Keywords | ||||
| Type 2 Diabetes; mast cells; tryptase | ||||
|
Statistics Article View: 20 PDF Download: 19 |
||||
